Clinical trials
Hospitalized Patients clinical trials
Below are recruiting hospitalized patients clinical trials, each written for real people, not researchers. We’re tracking 3,422 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04642430RecruitingPhase 4
Test of blood thinners comparing rivaroxaban vs apixaban
This trial compares the bleeding risk of two commonly used blood thinners—rivaroxaban and apixaban—in people with atrial fibrillation (AF). If you’re starting an anticoagulant for a new AF diagnosis, this may help doctors choose the safer option for you and others.
Victoria, British ColumbiaAges 18 years+ - NCT04533152Recruiting
Study risk factors for healing in diabetic foot ulcers
This study looks at what factors affect outcomes in adults with diabetic foot ulcers. It may help doctors better predict healing and complications by better understanding what influences progress.
CaenAges 18 years+ - NCT04370574Recruiting
Testing blood or tissue markers for suspected pancreatic cancer
This trial looks for “soluble biomarkers” (markers that can be found in body fluids like blood) for people who have a pancreatic mass and may have pancreatic ductal adenocarcinoma. The goal is to improve how pancreatic cancer is identified, especially using information taken from an endoscopic ultrasound biopsy.
Montpellier, MontpellierAges 18 years+ - NCT03997253Recruiting
Improving long-term survival after organ transplant
This study follows kidney, liver, or heart transplant recipients to better understand how to improve their long-term health and survival. Researchers at several hospitals in France will collect information from participants to learn what helps people stay healthy after a transplant.
LimogesAges 18 years+ - NCT03237026Recruiting
Urine tests to predict outcomes in prostate cancer treatment
This study looks for urine markers (proteins and metabolites) that may help predict how prostate cancer patients respond to treatment and what their outcomes are. You may be asked to give a urine sample and allow use of your medical and treatment details for analysis (results are not shared with you).
TaipeiAges 30–100 - NCT06534710Recruiting
Electronic moxibustion for pain and healing after brain surgery
This trial tests if a special heating device (electronic moxibustion) can reduce pain and help wounds heal faster after brain surgery. It may be an option if you are recovering well three days after surgery.
Yiwu, ZhejiangAges 18–80 - NCT06992076Recruiting
Hemophilia patients' experience with marstacimab treatment
This registry study follows people with hemophilia A or B who are taking marstacimab as their regular preventive treatment. It aims to understand how the medicine works in real life and how patients feel during treatment.
Xiamen, FujianAges 12 years+ - NCT07176494Recruiting
Revision of Deep Brain Stimulator in Parkinson's Disease
This study is for people with Parkinson's disease who need to have their deep brain stimulator (a device that sends electrical pulses to control movement) replaced or adjusted. The researchers want to learn the best way to do this procedure safely.
Ankara, Yenimahalle\AnkaraAges 40–85 - NCT07327606Recruiting
Heart, kidney, and metabolism health study
This study follows people with different stages of heart-kidney-metabolic syndrome to understand what factors affect their health over time. It aims to find better ways to predict and manage the condition.
Beijing, Beijing MunicipalityAges 18–85 - NCT06092281Recruiting
Can questionnaires improve follow-up after ESD?
This trial tests whether sending questionnaires and feedback helps patients keep up with their follow-up appointments after having a precancerous growth removed from the digestive tract (a procedure called ESD). It aims to see if this approach can make a difference in how well patients stick to their recommended check-ups.
Xi'an, ShaanxiAges 18–80 - NCT03058185Recruiting
Study of people with LMNA or EMD gene mutations
This study follows people who have a confirmed harmful (pathogenic) mutation in the LMNA and/or EMD gene. It aims to better understand these conditions through regular follow-up and health information collection, which may help improve future care.
Angers, AngersAges Any age - NCT06032052RecruitingPhase 2
Chemo plus immunotherapy for older adults with metastatic lung cancer
This trial tests a combination of chemotherapy and immunotherapy for people 65 or older with metastatic non-small cell lung cancer that has not been treated before and expresses PD-L1. It aims to see if this treatment can help control the cancer.
Wuhan, HubeiAges 65 years+ - NCT07858760Recruiting
Palliative care journey from home to hospital
This study looks at the experiences of patients who come to the palliative care unit at Strasbourg University Hospital from home or through the emergency department. It aims to understand their care path to improve support for others.
StrasbourgAges 18 years+ - NCT06791603Recruiting
Social media videos for chemo side effects
This study tests whether education delivered through social media videos can help breast cancer patients manage chemotherapy side effects. If you are starting chemotherapy for the first time and can use a smartphone, you may be able to join.
New Taipei CityAges 18 years+ - NCT04389463Recruiting
Study of heart surgery outcomes during COVID-19
This study looks at how people do after heart or chest surgery when they test positive for COVID-19. It may help doctors understand risks and outcomes for surgical patients during the pandemic.
NantesAges 18 years+ - NCT06680895Recruiting
FeNO study in ICU patients with breathing support
This study measures a lung inflammation marker called FeNO in ICU patients on a breathing machine. It may help doctors understand lung health and guide treatment.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07024433Recruiting
No-breathing-tube surgery for early lung cancer
This study tests a special 'tubeless' anesthesia technique — avoiding breathing tubes during surgery — for people with early-stage lung cancer. The goal is to see if it reduces lung problems after the operation.
Fuzhou, FujianAges 18–70 - NCT04720365Recruiting
Home video game rehab to help Parkinson’s walking and balance
This trial tests whether a serious (therapeutic) home video-game program can improve walking and balance problems for people with Parkinson’s disease who still have trouble even with levodopa. It also looks at whether the approach is worth it in real-world care (cost and benefits).
BordeauxAges 18 years+ - NCT02456974Recruiting
Testing how antibiotics are dosed in children’s intensive care
This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.
GhentAges 1 day–16 years - NCT05749276RecruitingPhase 1
Daratumumab with chemo for older adults with high-risk AML
This Phase 1 study tests whether adding daratumumab to standard intensive chemotherapy (idarubicin and cytarabine) works safely in people age 60 or older with a higher-risk form of acute myeloid leukemia (AML). It may help improve outcomes, but the main goal is to find the best dosing and safety in this age group.
NantesAges 60 years+ - NCT07122869Recruiting
Walk-in clinic study for emergency department patients
This study looks at whether patients sent to the emergency room by their general practitioner could be treated in a walk-in clinic instead. It aims to find better ways to manage care for stable patients.
Gonesse, FranceAges 18 years+ - NCT05339568Recruiting
Smartphone support program for people with advanced lung cancer
This trial tests a “whole process follow-up” care plan, using a smartphone, to support people with non-small cell lung cancer from diagnosis through treatment and follow-up. It may help you manage care steps more smoothly if you’re not a candidate for curative (radical) treatment or don’t want surgery.
Jinan, ShandongAges 18 years+ - NCT06974123Enrolling by invitationPhase 1/Phase 2
Testing a new oral drug for radiation proctitis
This trial tests an oral drug called Teslanbaicin for people who have pelvic cancer and developed radiation proctitis (inflammation of the rectum from radiation therapy). The goal is to see if it is safe and helps heal the inflammation.
Xinxiang, HenanAges 18 years+ - NCT06663748RecruitingPhase 2
ARX788 for HER2-positive metastatic breast cancer
This trial studies a new drug called ARX788 for people with HER2-positive breast cancer that has spread or cannot be removed. It aims to see if the drug can shrink tumors and help patients live longer.
Zhengzhou, HenanAges 18–75
Hear when a new Hospitalized Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalized patients?
- Yes. Clin2 currently lists 3,422 recruiting hospitalized patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalized patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalized patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.